Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jianguo Wang has a total of 198 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Production and nutrient-utilization responses to Bacillus licheniformis-containing direct-fed microbials in cattle: a design-adjusted multilevel meta-analysis

    by Zhibo Zeng, Na Lv, Jiajun Huang, Yuqing Cao, Yan Huang, Yazhou Wang, Chenxu Zhao, Bingyu Shen, Xiaoyan Zhu, Muhammad Farhan Rahim, et al.

  • Open Access

    Parity-dependent plasma and milk metabolomic remodeling across hyperketonemia in Holstein cows

    by Yan Huang, Bingyu Shen, Bihong Zhang, Juan J. Loor, Yazhou Wang, Chenxu Zhao, Zhibo Zeng, Danielle Fonseca, Jianguo Wang

  • Open Access

    Prepartum maternal chromium propionate supplementation improves neonatal calf antioxidant status by reshaping meconium microbiota and butyrate metabolism

    by Yuzhen Sui, Yong Dong, Yu Long, Jiajian Zhang, Yafei Zeng, Chenxu Zhao, Yazhou Wang, Zhibo Zeng, Bingyu Shen, Xiaoyan Zhu, et al.

    Neonatal calves experience considerable oxidative and metabolic challenges during the transition from intrauterine to extrauterine life, but whether maternal chromium propionate (CrPro) supplementation before calving improves neonatal antioxidant status through early-life microbial metabolism remains unclear. This study evaluated the effects of prepartum maternal CrPro supplementation on antioxidant capacity and microbial metabolic characteristics in neonatal calves. Forty-eight prepartum Holstein cows were randomly assigned to 3 dietary treatments (16 cows per treatment). After application of prespecified eligibility criteria, 30 dam–calf pairs were analyzed (10 replicates per treatment; maternal body weight, 651.87 ± 2.84 kg; parity, 2.40 ± 0.13; body condition score, 3.48 ± 0.03; means ± SEM). From 21 d before expected calving until parturition, cows received a basal total mixed ration without supplemental CrPro (Con) or the same ration supplemented with CrPro at 10 g·cow⁻¹·d⁻¹ (CrL) or 20 g·cow⁻¹·d⁻¹ (CrH), providing 4 and 8 mg Cr(III)·cow⁻¹·d⁻¹, respectively. Calf blood and meconium samples were collected within 30 min after birth and before colostrum intake. Calves in the CrH group had greater body weight than Con calves at birth and at 7 and 14 d of age (P ≤ 0.05). Maternal CrPro supplementation dose-dependently increased calf plasma Cr(III). Compared with Con, CrH increased total antioxidant capacity (P < 0.05) and catalase activity (P < 0.001), decreased malondialdehyde (P < 0.01), and increased meconium short-chain fatty acid concentrations (P < 0.001). Plasma Cr(III) was positively correlated with antioxidant and short-chain fatty acid measures and negatively correlated with malondialdehyde (all P < 0.05). Metagenomic analysis indicated that CrH enriched a butyrate-producing microbial consortium, strengthened microbial co-occurrence networks, and increased the microbial potential for butyrate synthesis. Plasma metabolomics identified the oxidized phosphatidylcholine PAz-PC as a major negative mediator of catalase activity. Integrated analyses suggested two complementary pathways: meconium butyrate may enhance catalase activity through Nrf2/HO-1 signaling, whereas reduced plasma PAz-PC may relieve catalase inhibition. In conclusion, prepartum maternal CrPro supplementation improved antioxidant capacity in newborn calves, potentially through enrichment of butyrate-producing bacteria and attenuation of PAz-PC-associated catalase inhibition, providing a maternal nutritional strategy to support early-life antioxidant health in neonatal ruminants.

  • Open Access

    Choline attenuates NEFA-induced glucose metabolic dysregulation in calf hepatocytes via the modulation of the expression of key metabolic genes

    by Honghao Wang, Lamei Wang, Lihua Ma, Shaoya Wang, Thant Mon Paing, Ruiting Zhang, Shimin Liu, Jianguo Wang, Junhu Yao, Shengru Wu, et al.

    Negative energy balance (NEB) in periparturient dairy cows elevates non-esterified fatty acids (NEFAs), disrupting hepatic glucose homeostasis. Choline (vitamin B4), an essential dietary micronutrient and functional food ingredient, shows hepatoprotective potential, yet its genomic regulation of glucose metabolism remains unclear. Using an in vitro model of calf primary hepatocytes, this study investigated the effects of choline on NEFAs-induced glucose metabolic disruptions and the underlying signaling pathways. The results showed that supplementation with 75 μM choline alleviated 1.2 mM NEFA-induced hepatocyte injury, as evidenced by significant reductions in AKP, AST, and ALT levels. At the molecular level, choline treatment up-regulated the mRNA expression of glucose transporter (SGLT1), key gluconeogenic enzymes (PC, PEPCK, and G6PC), and glycogen synthase (GYS2), thereby promoting both gluconeogenesis and glycogen synthesis. Transcriptomic analysis further revealed that choline may improve glucose homeostasis by upregulating SOCS3 to inhibit the JAK-STAT pathway and by modulating the mRNA expression of IGFBP1, IGFBP4, and IGFBP7 within the IGF system. Collectively, these findings provide a theoretical foundation for the use of choline supplementation to mitigate NEB-associated metabolic disorders in dairy cows.

  • Open Access

    Choline attenuates NEFA-induced glucose metabolic dysregulation in calf hepatocytes via the modulation of the expression of key metabolic genes

    by Honghao Wang, Lamei Wang, Lihua Ma, Shaoya Wang, Thant Mon Paing, Ruiting Zhang, Shimin Liu, Jianguo Wang, Junhu Yao, Shengru Wu, et al.

    Negative energy balance (NEB) in periparturient dairy cows elevates non-esterified fatty acids (NEFAs), disrupting hepatic glucose homeostasis. Choline (vitamin B4), an essential dietary micronutrient and functional food ingredient, shows hepatoprotective potential, yet its genomic regulation of glucose metabolism remains unclear. Using an in vitro model of calf primary hepatocytes, this study investigated the effects of choline on NEFAs-induced glucose metabolic disruptions and the underlying signaling pathways. The results showed that supplementation with 75 μM choline alleviated 1.2 mM NEFA-induced hepatocyte injury, as evidenced by significant reductions in AKP, AST, and ALT levels. At the molecular level, choline treatment up-regulated the mRNA expression of glucose transporter (SGLT1), key gluconeogenic enzymes (PC, PEPCK, and G6PC), and glycogen synthase (GYS2), thereby promoting both gluconeogenesis and glycogen synthesis. Transcriptomic analysis further revealed that choline may improve glucose homeostasis by upregulating SOCS3 to inhibit the JAK-STAT pathway and by modulating the mRNA expression of IGFBP1, IGFBP4, and IGFBP7 within the IGF system. Collectively, these findings provide a theoretical foundation for the use of choline supplementation to mitigate NEB-associated metabolic disorders in dairy cows.

  • Open Access

    Establishment and characterization of an immortalized bovine luteal cell line

    by Guoqing Fei, Zefang Zhao, Minghua Zeng, Yue Liang, Ting Miao, Yanqiu Liu, Jiayao Yang, Shulin Chen, Xiaoyan Zhu, Jianguo Wang

    The bovine corpus luteum (CL) is critical for pregnancy establishment and maintenance via progesterone (P 4 ) secretion. Primary bovine luteal cells (PBLC), the core in vitro model for reproductive and steroidogenesis research, are severely limited by high isolation cost, cellular heterogeneity, and restricted proliferative capacity. In this study, we established an immortalized bovine luteal cell line with stable in vitro proliferative capacity, termed SV40 T-immortalized bovine luteal cells (SV40T-IBLC), via lentiviral transduction of the Simian virus 40 (SV40) T antigen gene. The immortalized cells displayed a typical epithelial-like morphology with abundant small cytoplasmic lipid droplets. They secreted multiple functional hormones including P 4 and oxytocin, expressed synaptophysin, a key marker protein of mature functional luteal cells, and maintained stable expression of core steroidogenic genes and proteins such as STAR, 3β-hydroxysteroid dehydrogenase (3β-HSD), CYP11A1, and PTGFR, with mRNA levels of these key genes showing no significant difference from those of parallel-cultured PBLC. Functionally, SV40T-IBLC exhibited time-dependent P 4 secretion, with P 4 concentration in the culture supernatant reaching 1.89 ± 0.14 ng/mL at 60 h, which was fully consistent with the secretory level and dynamic pattern of PBLC. After continuous in vitro culture up to the 50th passage, the cells maintained a normal diploid karyotype (29 pairs of autosomes and 1 pair of XX sex chromosomes), and no evidence of malignant transformation was observed in the anchorage-independent growth assay and in vivo tumorigenicity assay in nude mice. Furthermore, Co-culture with SV40T-IBLC significantly enhanced the viability of bovine endometrial epithelial cells (BEEC) by 34.2% after 72 h of co-incubation ( p < 0.01), increased intracellular lipid droplet abundance of BEEC, and upregulated the mRNA expression of endometrial receptivity-related genes including EGF and LIF, with no significant alteration in BEEC apoptosis rate. In conclusion, this immortalized cell line retains core functional characteristics of PBLC, providing a stable, homogeneous in vitro model for bovine reproductive research.

  • Open Access

    Aloperine alleviates LPS-induced inflammation in bovine intestinal epithelial cells through autophagy and TLR4/p38 MAPK/NF-κB pathway

    by Panpan Tan, Yazhou Wang, Cai Zhang, Qinghua Deng, Liyin Du, Baoyu Zhao, Gulman Muhametbay, Chenxu Zhao, Jianguo Wang

    Background: Calf diarrhea is a major cause of mortality and morbidity, leading to substantial economic losses in the cattle industry. Aloperine (Alo) exhibits an anti-inflammation effect and alleviates dextran sulfate sodium salt (DSS)-induced colitis; however, it remains unclear whether Alo alleviates calf diarrhea-induced intestinal inflammation. Results: In this study, network pharmacology was used to discover the possible mechanism of Alo on the anti-inflammatory effect; Then, an inflammation model was induced by LPS in BIECs-21 to evaluate the protective effect of Alo on LPS-induced inflammation. Results found that a total of 68 overlapping targets of Alo and inflammation were obtained, among which ALB, AKT1, IL-6, and EGFR exhibited good affinity for Alo. In vitro experiments, Alo inhibited LPS-induced pro-inflammatory cytokine levels, increased the expression of ZO-1 and Claudin 1, and reduced the expression of proteins related to autophagy and TLR4/p38 MAPK/NF-κB pathway; the autophagy inhibitor CQ and Baf A1 results further demonstrated that Alo inhibited late stages of autophagy maturation and impaired intestinal epithelial barrier function. Conclusions: These results indicated that Alo has protective effects on LPS-induced inflammation by decreasing the levels of the pro-inflammatory cytokines through the TLR4/p38 MAPK/NF-κB pathway, inhibiting late stages of autophagy maturation, and impairing intestinal epithelial barrier function.


  • Open Access

    Choline attenuates NEFA-induced hepatic steatosis via GNMT regulation in hepatocytes

    by Xueer Du, Lamei Wang, Yanfei Dai, Jing Lu, Hongrui Li, Dangdang Wang, Jun Zhang, Chuanjiang Cai, Shimin Liu, Junhu Yao, et al.

    To elucidate the molecular mechanisms by which choline regulates hepatic lipid metabolism under negative energy balance conditions, we established non-esterified fatty acid (NEFA)-induced hepatic steatosis models in both calf primary hepatocytes and human LO2 hepatocytes. Choline supplementation significantly reduced intracellular triglyceride accumulation and cytotoxicity induced by NEFA exposure. Transcriptomic profiling identified glycine N-methyltransferase (GNMT) as a key differentially expressed gene. Subsequent experiments confirmed that choline upregulated GNMT expression at both the mRNA and protein levels in a concentration-dependent manner. Knockdown of GNMT reversed the beneficial effects of choline on genes related to lipid synthesis (FAS, ACC), fatty acid oxidation (CPT1), lipoprotein assembly (ApoB100, MTTP), and bile acid metabolism (CYP7A1, CYP27A1, BSEP). Furthermore, inhibition of AMP-activated protein kinase (AMPK) reduced GNMT protein expression and elevated Myc, a negative transcriptional regulator of GNMT, suggesting that choline may regulate GNMT through the AMPK/Myc axis. Collectively, our findings demonstrate that choline alleviates NEFA-induced lipid accumulation and hepatocellular damage by modulating lipid and bile acid metabolism through GNMT, with the AMPK/Myc/GNMT signaling axis playing a pivotal regulatory role. These results provide mechanistic insights into the hepatic protective effects of choline and suggest GNMT as a potential therapeutic target for metabolic disorders in dairy cows and beyond.


  • Open Access

    Effects of chromium propionate supplementation on production performance, blood parameters, ruminal fermentation indices, and microbial diversity in heat-stressed Holstein dairy cows

    by Bihong Zhang, Yongqiang Wen, Zixin Zhang, Qimin Liu, Yazhou Wang, Chenxu Zhao, Jianguo Wang

    Global warming increases the risk of heat stress in dairy cattle, thereby jeopardizing their health and the economic benefits of dairy farms. Chromium propionate (CrPro) is a chromium source permitted for use in feed additives. However, research on the effects of CrPro on heat-stressed dairy cows is limited. Therefore, this study assessed the effects of different doses of CrPro on heat-stressed dairy cows. Holstein dairy cows with similar body condition, milk yield, and parity were randomly divided into three groups: the control group (Con), the low-dose group (CrL), and the high-dose group (CrH), with 10 cows per group. CrPro was supplemented at doses of 0, 4, and 8 mg/(d·cow) in the basal diets of each group, respectively. The trial lasted for 45 days. The temperature-humidity index (THI) in the cowshed was monitored daily to assess the heat stress status of the cows. Daily milk yield was recorded, and rectal temperature was measured according to experimental requirements. Milk composition, antioxidant capacity, liver enzyme activity, lipid metabolism, and other parameters were analyzed. The composition and diversity of the rumen microbiota were also assessed. Results showed that the average THI in the cowshed during the trial period (0–45 days) was 74.97 ± 2.85, indicating that dairy cows used in this study experienced mild heat stress. Compared with the Con group, the CrL and CrH groups had reduced rectal temperature and respiratory rate. The CrH group had significantly lower milk yield loss and somatic cell count (p < 0.05). No significant differences were observed in milk composition, antioxidant capacity, liver enzyme activity, or lipid metabolism between the CrL and CrH groups (p > 0.05). Compared with the CrH group, the CrL group had lower volatile fatty acids (VFAs) (acetate, propionate, butyrate, isobutyrate, valerate, and isovalerate) in rumen fluid. Compared with the control group, both CrL and CrH groups exhibited enhanced microbial abundance and an optimized ruminal community structure. Overall, an 8 mg/(d·cow) dose of CrPro had a greater impact on improving production performance and economic benefits. The findings of this study provide data support for selecting an appropriate CrPro dosage to reduce heat stress-induced economic losses on dairy farms.


  • Choline reduces inflammatory response and lipid accumulation in calf hepatocytes induced by NEFA via inhibiting ROS/ NF-κB/NLRP3 inflammasome axis

    by Rui Zhang, Xueer Du, Haitao Hu, Juanfang Chen, Junjian Yu, Lamei Wang, Junhu Yao, Shimin Liu, Jianguo Wang, Yangchun Cao